Subsequently, antigen-presenting cells (APCs) represented by DCs, could migrate to the draining lymph nodes and present antigens to CTLs, killing tumor cells presenting the major histocompatibility complex (MHC). This evidence concerns the gene HLA-C and neoplasm.